BioMosaics, Inc.'s Glypican-3 Antibody (clone 1G12) Validated at PhenoPath Laboratories for Immunohistochemical Detection of Liver Cancer
3/26/2009 11:38:40 AM
More...
|
BioMosaics, Inc.'s Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
9/11/2007 11:40:32 AM
More...
|
BioMosaics, Inc.'s Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
9/10/2007 12:15:44 PM
More...
|
BioMosaics, Inc. Announces Products For Detection Of The Glypican-3 Biomarker In Human Tissue And Serum
7/14/2006 1:08:52 PM
More...
|
BioMosaics, Inc. Initiates Study To Assess Biomarker Responses In Occupational Exposure To Butadiene
10/19/2005 5:10:30 PM
More...
|
BioMosaics, Inc. Licenses Novel Diagnostic Test For Primary Liver Cancer From Toronto Hospital
10/19/2005 5:09:17 PM
More...
|